Screener
enGene Therapeutics Inc. ENGN Q3 2025 earnings
Reported September 10, 2025 · Before market open
EPS-$0.57Miss by $0.07
EPS estimate-$0.50
Next report
Date not yet announcedVersus estimates
Diluted EPS
FAQ
- When did enGene Therapeutics Inc. report Q3 2025 earnings?
- enGene Therapeutics Inc. (ENGN) reported Q3 2025 earnings on September 10, 2025 before market open.
- What were enGene Therapeutics Inc.'s Q3 2025 revenue and EPS?
- enGene Therapeutics Inc. reported eps of $-0.57 for Q3 2025.
- Did enGene Therapeutics Inc. beat estimates in Q3 2025?
- EPS missed the consensus estimate of $-0.50 by $0.07.
- How did enGene Therapeutics Inc.'s Q3 2025 results compare year-over-year?
- Compared to the same quarter a year prior, eps declined 78.1% from $-0.32.
- Where can I find enGene Therapeutics Inc.'s Q3 2025 SEC filings?
- You can read the 8-K earnings release (0000950170-25-114220) and the 10-Q periodic report (0000950170-25-114224) directly on SEC EDGAR. The filing index links above go to sec.gov.
